✦ LIBER ✦

Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

✍ Scribed by Neubauer, Marcus A.; Garfield, David H.; Kuerfler, Paul R.; Raju, Robert N.; Lindquist, Deborah L.; Soo, Edward W.; Khan, Myrna; Boehm, Kristi A.; Asmar, Lina

Book ID: 119318994
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 98 KB
Volume: 47
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2004.05.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of weekly docetaxel and g

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

✍ Sujith Kalmadi; Giles McNeill; Mellar Davis; David Peereboom; David Adelstein; T 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 68 KB

Front-line treatment of advanced non-sma

Front-line treatment of advanced non-small cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial

✍ Georgoulias, V; Kourousis, Ch; Androulakis, N; Kakolyris, S; Dimopoulos, MA; Pap 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Phase II trial of weekly docetaxel and g

Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer

✍ Park, Se Hoon; Hong, Junshik; Kim, Young Saing; Kim, Yujin; Kyung, Sun Young; An 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Weekly docetaxel as first-line therapy f

Weekly docetaxel as first-line therapy for elderly patients with advanced non-small cell lung cancer (NSCLC)

✍ Hainsworth, J.D; Burris, H.A; Morrissey, L.H; Litchy, S; Greco, F.A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Docetaxel versus docetaxel plus gemcitab

Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial

✍ Georgoulias, Vassilis; Androulakis, Nikolaos; Kotsakis, Athanasios; Hatzidaki, D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Randomized Multicenter Phase II Study of

Randomized Multicenter Phase II Study of Gemcitabine Versus Docetaxel as First-Line Therapy with Second-Line Crossover in Advanced-Stage Non–Small-Cell Lung Cancer

✍ Christian Manegold; Lothar Richard Pilz; Gabriele Koschel; Katrin Schott-von Röm 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 158 KB